COLL vs ROL · P/E 17, rev $181.9M vs P/E 41, rev $3.39B
Collegium Pharmaceutical Inc (COLL) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the COLL and ROL stock pages for the full models.
Not investment advice.